CASE REPORT: A patient with residual craniopharyngioma experienced a rapid tumor relapse during growth hormone therapy. OBJECTIVE: We present this case and remind physicians that it is necessary to reevaluate the safety of growth hormone therapy in patients with residual craniopharyngioma.
CASE REPORT: A patient with residual craniopharyngioma experienced a rapid tumor relapse during growth hormone therapy. OBJECTIVE: We present this case and remind physicians that it is necessary to reevaluate the safety of growth hormone therapy in patients with residual craniopharyngioma.
Authors: Aaron J Clark; Tene A Cage; Derick Aranda; Andrew T Parsa; Peter P Sun; Kurtis I Auguste; Nalin Gupta Journal: Childs Nerv Syst Date: 2012-10-23 Impact factor: 1.475
Authors: Michael E Sughrue; Isaac Yang; Ari J Kane; Shanna Fang; Aaron J Clark; Derrick Aranda; Igor J Barani; Andrew T Parsa Journal: J Neurooncol Date: 2010-06-10 Impact factor: 4.130